Gerard F Anderson
Datos Biográficos
| ID | 3929936 |
|---|---|
| NOMBRE | Gerard F Anderson |
| NOMBRES | Gerard F |
| APELLIDO | Anderson |
| FIRMA | ANDERSON G F |
| AFILIACIONES | Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland |
| VERIFICADO | No |
| TOTAL DE OBRAS | 22 |
| TOTAL DE CITAS | 3 |
| TOTAL COMO AUTOR | 22 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 1990 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2023 |
| ÍNDICE H | 1 |
Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
This cross-sectional study uses Medicare Part D claims for high-utilization generic drugs to analyze gross profits accumulated by pharmacy benefit managers, pharmacies, wholesalers, and manufacturers in the pharmaceutical supply chain
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
This cohort study demonstrated that the $2000 out-of-pocket cap included in the Inflation Reduction Act may substantially moderate the potential increase in spending faced by individuals who use ultra-expensive drugs when moving from commercial insurance to Part D coverage
Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications
The findings of this cross-sectional study indicate that the current product-level methods to estimate drug price inflation underestimated price increases for HCV drugs by failing to include the high launch prices of new market entrants. Using a class-level approach, the index captured higher spending on new products at launch. Prescription-level analyses, which did not consider shorter durations of treatment, overestimated price increases
The Role of Advance Purchasing Commitments in Government Drug Price Negotiations
Older Americans’ Preferences Between Lower Drug Prices and Prescription Drug Plan Choice, 2019
Objectives. To assess older Americans’ willingness to trade off the possibility of choosing or changing their prescription drug plan for lower drug spending. Methods. We used data from the Kaiser Family Foundation Health Tracking Poll on prescription drugs carried out in February 2019. This nationwide telephone survey oversampled participants aged 65 years and older who, when weighted, were representative of the US older adult population. Results…
Pharmaceutical Industry Support of US Patient Advocacy Organizations
Objectives. To examine whether the share of pharmaceutical industry funds allocated to patient advocacy organizations (PAOs) is disproportionately large in the United States relative to other industrialized countries and to compare pharmaceutical companies’ disclosure practices across industrialized countries. Methods. We examined funding of PAOs among the 10 largest pharmaceutical companies in 2016. We compared funding allocated to organizations…
Multiple Chronic Conditions and Life Expectancy
BACKGROUND: The number of people living with multiple chronic conditions is increasing, but we know little about the impact of multimorbidity on life expectancy. OBJECTIVE: We analyze life expectancy in Medicare beneficiaries by number of chronic conditions. RESEARCH DESIGN: A retrospective cohort study using single-decrement period life tables. SUBJECTS: Medicare fee-for-service beneficiaries (N=1,372,272) aged 67 and older as of January 1, 2008…
Continuity of Care and Its Effect on Prescription Drug Use Among Medicare Beneficiaries With Hypertension
BACKGROUND: Continuity of care is one of the pillars of primary care; yet, it is unclear whether having a regular physician influences the use of prescription drugs among the elderly. OBJECTIVE: To assess the effect of continuity of care on prescription drug use for Medicare beneficiaries with hypertension. METHODS: Medicare beneficiaries age 67 years and older were categorized in 3 groups according to the level of continuity of care experienced …
Hospice Care and Resource Utilization in Medicare Beneficiaries With Heart Failure
BACKGROUND: Although hospice use may be increasing among heart failure patients, its association with both cost and intensity of care in this population has not been well examined. OBJECTIVE: To assess the association of hospice care with resource utilization among a national sample of Medicare beneficiaries with heart failure during the last 6 months of life. METHODS: We performed a cross-sectional analysis of the 5% sample of Medicare claims da…
Incorporating New Research Into Medicare Risk Adjustment
BACKGROUND: The Medicare Advantage payment system underpays health plans that enroll beneficiaries with multiple and complex chronic conditions. OBJECTIVES: This article addresses 3 major problems in the current payment system: (1) underreporting of chronic disease prevalence in fee-for-service (FFS) Medicare claims data, (2) overpayment of healthier and underpayment of sicker beneficiaries in the current payment system, and (3) underpayment for …
Comorbidity and Outcomes of Coronary Artery Bypass Graft Surgery at Cardiac Specialty Hospitals Versus General Hospitals
BACKGROUND: Cardiac specialty hospitals assert better patient outcomes and efficiency, whereas general hospitals contend they attract healthier patients. OBJECTIVES: To ascertain whether increased cardiac specialization of a hospital's services is associated with improved outcomes for coronary artery bypass graft (CABG) surgery and whether patients with and without comorbid disease have equivalent outcomes to their counterparts at general hospita…
Chronic Medical Illness, Depression, and Use of Acute Medical Services Among Medicare Beneficiaries
BACKGROUND: This study assessed the relation of comorbid depressive syndrome with utilization of emergency department services and preventable inpatient hospitalizations among elderly individuals with chronic medical conditions. RESEARCH DESIGN: A cross-sectional study. SETTING: Individuals greater than or equal to 65 years of age living in the United States with Medicare part A and B fee-for-service coverage in 1999. SUBJECTS: A 5% random sample…
It’s The Prices, Stupid
This paper uses the latest data from the Organization for Economic Cooperation and Development (OECD) to compare the health systems of the thirty member countries in 2000. Total health spending--the distribution of public and private health spending in the OECD countries--is presented and discussed. U.S. public spending as a percentage of GDP (5.8 percent) is virtually identical to public spending in the United Kingdom, Italy, and Japan (5.9 perc…
The Blues
Jaap Kooijman. ... And the Pursuit of National Health: The Incremental Strategy toward National Health Insurance in the United States of America. Amsterdam Monographs in American Studies, no. 8. Amsterdam: Editions Rodopi, 1999. xi + 262 pp. $44.00; Hfl. 80.00 (cloth); F. 240.00; £26.00 (paperbound)
State Regulation of Managed Care
As more and more children enroll in managed care, states have responded to concerns expressed by their constituents by passing legislation and developing credentialing requirements to assist families with children in receiving appropriate care from managed care plans. Although most of the legislation and credentialing requirements apply to the population generally, a few provisions apply specifically to children. The legislation and credentialing…
Cross-Cultural Differences in the Reporting of Global Functional Capacity
OBJECTIVES: Patient-based health status measures have an important role to play in the assessment of health care outcomes. Among these measures, global assessments increasingly have been used, although the understanding of the performance of these indicators and the determinants of patients responses is underdeveloped. In this study, the performance of a single-item global indicator of visual function in cataract patients of four international se…
Technology Coverage Decisions by Health Care Plans and Considerations by Medical Directors
OBJECTIVES: Decisions made by private health care plans as to whether to cover new medical technology have a significant impact on access, diffusion, and costs. This study describes the variation in health plan coverage of different laser technologies and the types of considerations used in making coverage decisions for them. METHODS: In a cross-sectional national survey of medical directors at private plans, medical directors indicated current c…
Patients' acceptance of waiting for cataract surgery
The patient's perspective about waiting for elective surgery is an important consideration in the management of waiting lists, yet it has received little attention to date. This study was undertaken to assess the acceptability of personal waiting times from the perspective of patients, and to examine waiting time and patient characteristics associated with the perception that a wait for cataract surgery is too long. The international prospective …
The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients
Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…
Analyzing Health Outcomes Through International Comparisons
There is increasing interest in the conduct of international studies that compare health care outcomes. This paper draws from the literature in sociology, anthropology, and psychology to examine the problems that can be encountered when collecting primary data for comparative purposes. Issues of study design, selection, development, and adaptation of instruments, problems encountered in collecting primary data, and techniques for analyzing compar…
Accuracy of Medicare Claims Data for Estimation of Cancer Incidence and Resection Rates Among Elderly Americans
To explore the reliability of Medicare Part A claims data for clinical and health services research related to the care of patients with cancer, the authors compared estimates of the incidence of and resection rates for cancer of the breast, colon, and lung derived from analysis of Medicare Part A data versus data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Incidence rates of breast, colon, and…
Risk Reduction From Low Osmolality Contrast Media
Decisions regarding the use of and reimbursement for new medical technologies frequently involve complex cost-quality trade-offs. Among physicians, hospital administrators, and insurers, interindividual variation in the value of benefits attributable to these technologies often leads to conflicting opinions about their appropriate use. Although society now encourages patient involvement in such decisions, few methods for obtaining patient valuati…
Patients' acceptance of waiting for cataract surgery
The patient's perspective about waiting for elective surgery is an important consideration in the management of waiting lists, yet it has received little attention to date. This study was undertaken to assess the acceptability of personal waiting times from the perspective of patients, and to examine waiting time and patient characteristics associated with the perception that a wait for cataract surgery is too long. The international prospective …
Pharmaceutical Industry Support of US Patient Advocacy Organizations
Objectives. To examine whether the share of pharmaceutical industry funds allocated to patient advocacy organizations (PAOs) is disproportionately large in the United States relative to other industrialized countries and to compare pharmaceutical companies’ disclosure practices across industrialized countries. Methods. We examined funding of PAOs among the 10 largest pharmaceutical companies in 2016. We compared funding allocated to organizations…
Risk Reduction From Low Osmolality Contrast Media
Decisions regarding the use of and reimbursement for new medical technologies frequently involve complex cost-quality trade-offs. Among physicians, hospital administrators, and insurers, interindividual variation in the value of benefits attributable to these technologies often leads to conflicting opinions about their appropriate use. Although society now encourages patient involvement in such decisions, few methods for obtaining patient valuati…
Accuracy of Medicare Claims Data for Estimation of Cancer Incidence and Resection Rates Among Elderly Americans
To explore the reliability of Medicare Part A claims data for clinical and health services research related to the care of patients with cancer, the authors compared estimates of the incidence of and resection rates for cancer of the breast, colon, and lung derived from analysis of Medicare Part A data versus data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Incidence rates of breast, colon, and…
The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients
Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…
Analyzing Health Outcomes Through International Comparisons
There is increasing interest in the conduct of international studies that compare health care outcomes. This paper draws from the literature in sociology, anthropology, and psychology to examine the problems that can be encountered when collecting primary data for comparative purposes. Issues of study design, selection, development, and adaptation of instruments, problems encountered in collecting primary data, and techniques for analyzing compar…
Technology Coverage Decisions by Health Care Plans and Considerations by Medical Directors
OBJECTIVES: Decisions made by private health care plans as to whether to cover new medical technology have a significant impact on access, diffusion, and costs. This study describes the variation in health plan coverage of different laser technologies and the types of considerations used in making coverage decisions for them. METHODS: In a cross-sectional national survey of medical directors at private plans, medical directors indicated current c…
Patients' acceptance of waiting for cataract surgery
The patient's perspective about waiting for elective surgery is an important consideration in the management of waiting lists, yet it has received little attention to date. This study was undertaken to assess the acceptability of personal waiting times from the perspective of patients, and to examine waiting time and patient characteristics associated with the perception that a wait for cataract surgery is too long. The international prospective …
State Regulation of Managed Care
As more and more children enroll in managed care, states have responded to concerns expressed by their constituents by passing legislation and developing credentialing requirements to assist families with children in receiving appropriate care from managed care plans. Although most of the legislation and credentialing requirements apply to the population generally, a few provisions apply specifically to children. The legislation and credentialing…
Cross-Cultural Differences in the Reporting of Global Functional Capacity
OBJECTIVES: Patient-based health status measures have an important role to play in the assessment of health care outcomes. Among these measures, global assessments increasingly have been used, although the understanding of the performance of these indicators and the determinants of patients responses is underdeveloped. In this study, the performance of a single-item global indicator of visual function in cataract patients of four international se…
The Blues
Jaap Kooijman. ... And the Pursuit of National Health: The Incremental Strategy toward National Health Insurance in the United States of America. Amsterdam Monographs in American Studies, no. 8. Amsterdam: Editions Rodopi, 1999. xi + 262 pp. $44.00; Hfl. 80.00 (cloth); F. 240.00; £26.00 (paperbound)
It’s The Prices, Stupid
This paper uses the latest data from the Organization for Economic Cooperation and Development (OECD) to compare the health systems of the thirty member countries in 2000. Total health spending--the distribution of public and private health spending in the OECD countries--is presented and discussed. U.S. public spending as a percentage of GDP (5.8 percent) is virtually identical to public spending in the United Kingdom, Italy, and Japan (5.9 perc…
Chronic Medical Illness, Depression, and Use of Acute Medical Services Among Medicare Beneficiaries
BACKGROUND: This study assessed the relation of comorbid depressive syndrome with utilization of emergency department services and preventable inpatient hospitalizations among elderly individuals with chronic medical conditions. RESEARCH DESIGN: A cross-sectional study. SETTING: Individuals greater than or equal to 65 years of age living in the United States with Medicare part A and B fee-for-service coverage in 1999. SUBJECTS: A 5% random sample…
Comorbidity and Outcomes of Coronary Artery Bypass Graft Surgery at Cardiac Specialty Hospitals Versus General Hospitals
BACKGROUND: Cardiac specialty hospitals assert better patient outcomes and efficiency, whereas general hospitals contend they attract healthier patients. OBJECTIVES: To ascertain whether increased cardiac specialization of a hospital's services is associated with improved outcomes for coronary artery bypass graft (CABG) surgery and whether patients with and without comorbid disease have equivalent outcomes to their counterparts at general hospita…
Continuity of Care and Its Effect on Prescription Drug Use Among Medicare Beneficiaries With Hypertension
BACKGROUND: Continuity of care is one of the pillars of primary care; yet, it is unclear whether having a regular physician influences the use of prescription drugs among the elderly. OBJECTIVE: To assess the effect of continuity of care on prescription drug use for Medicare beneficiaries with hypertension. METHODS: Medicare beneficiaries age 67 years and older were categorized in 3 groups according to the level of continuity of care experienced …
Hospice Care and Resource Utilization in Medicare Beneficiaries With Heart Failure
BACKGROUND: Although hospice use may be increasing among heart failure patients, its association with both cost and intensity of care in this population has not been well examined. OBJECTIVE: To assess the association of hospice care with resource utilization among a national sample of Medicare beneficiaries with heart failure during the last 6 months of life. METHODS: We performed a cross-sectional analysis of the 5% sample of Medicare claims da…
Incorporating New Research Into Medicare Risk Adjustment
BACKGROUND: The Medicare Advantage payment system underpays health plans that enroll beneficiaries with multiple and complex chronic conditions. OBJECTIVES: This article addresses 3 major problems in the current payment system: (1) underreporting of chronic disease prevalence in fee-for-service (FFS) Medicare claims data, (2) overpayment of healthier and underpayment of sicker beneficiaries in the current payment system, and (3) underpayment for …
Multiple Chronic Conditions and Life Expectancy
BACKGROUND: The number of people living with multiple chronic conditions is increasing, but we know little about the impact of multimorbidity on life expectancy. OBJECTIVE: We analyze life expectancy in Medicare beneficiaries by number of chronic conditions. RESEARCH DESIGN: A retrospective cohort study using single-decrement period life tables. SUBJECTS: Medicare fee-for-service beneficiaries (N=1,372,272) aged 67 and older as of January 1, 2008…
Pharmaceutical Industry Support of US Patient Advocacy Organizations
Objectives. To examine whether the share of pharmaceutical industry funds allocated to patient advocacy organizations (PAOs) is disproportionately large in the United States relative to other industrialized countries and to compare pharmaceutical companies’ disclosure practices across industrialized countries. Methods. We examined funding of PAOs among the 10 largest pharmaceutical companies in 2016. We compared funding allocated to organizations…
Older Americans’ Preferences Between Lower Drug Prices and Prescription Drug Plan Choice, 2019
Objectives. To assess older Americans’ willingness to trade off the possibility of choosing or changing their prescription drug plan for lower drug spending. Methods. We used data from the Kaiser Family Foundation Health Tracking Poll on prescription drugs carried out in February 2019. This nationwide telephone survey oversampled participants aged 65 years and older who, when weighted, were representative of the US older adult population. Results…
The Role of Advance Purchasing Commitments in Government Drug Price Negotiations
Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
This cross-sectional study uses Medicare Part D claims for high-utilization generic drugs to analyze gross profits accumulated by pharmacy benefit managers, pharmacies, wholesalers, and manufacturers in the pharmaceutical supply chain
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
This cohort study demonstrated that the $2000 out-of-pocket cap included in the Inflation Reduction Act may substantially moderate the potential increase in spending faced by individuals who use ultra-expensive drugs when moving from commercial insurance to Part D coverage
Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications
The findings of this cross-sectional study indicate that the current product-level methods to estimate drug price inflation underestimated price increases for HCV drugs by failing to include the high launch prices of new market entrants. Using a class-level approach, the index captured higher spending on new products at launch. Prescription-level analyses, which did not consider shorter durations of treatment, overestimated price increases
Medicine (20 obras) · Health care (10 obras) · Healthcare Policy and Management (10 obras) · Business (9 obras) · Health Systems, Economic Evaluations, Quality of Life (8 obras) · Internal Medicine (8 obras) · Environmental health (7 obras) · Family medicine (7 obras) · Economics (6 obras) · Internal Medicine (6 obras)